Australia's E-Cigarette Rules Fizzle with Only 3,500 Prescriptions in First Month

Nov.11.2024
Australia's E-Cigarette Rules Fizzle with Only 3,500 Prescriptions in First Month
Australia’s new plan to include e-cigarettes in pharmacies saw slow sales in its first month, with only 3,500 units sold. Many pharmacists are reluctant to sell e-cigarettes due to ethical concerns or complicated procedures, leading to a surge in black market e-cigarette prices to 40-60 AUD.

According to a report from Watoday on November 9, despite an estimated one million Australians using e-cigarettes, in a plan implemented by the federal government to include e-cigarettes as pharmacy products to combat the black market, only 3,500 sales were made in the first month.

 

Australia has approximately 5800 pharmacies nationwide, but data shows that thousands of them do not dispense any e-cigarette products on prescription. The federal government's initial policy analysis assumed that once illegal products are harder to obtain, about 450,000 people will seek medical e-cigarette products.

 

However, many pharmacists have stated that they are unwilling to sell e-cigarettes due to moral reasons or because the process is too cumbersome. Illegal e-cigarettes are still widely available, but prices have soared to 40 to 60 Australian dollars per device as retailers increase prices to compensate for higher penalties.

 

Last week, officials at a Senate estimates hearing stated that they currently do not track how many pharmacies are selling e-cigarettes. Chief Medical Officer Tony Lawler said that obtaining a definitive answer is actually quite difficult.

 

Health Department official Chris Bedford provided data on the sale of e-cigarette products by pharmacies following patient consultations. He stated that the total number of these sales across Australia reached 3,500, and pharmacists are able to dispense multiple e-cigarette products based on notification, leading to patients coming in and engaging in conversations.

 

Anne Ruston, the Health spokesperson for the opposition party, stated that the number of e-cigarettes sold by pharmacies last month only accounted for a small fraction of estimated e-cigarette users in Australia.

 

"We know that most pharmacists do not want to become tobacco merchants, as clearly reflected in the department's statistics."

 

Due to e-cigarette products not being included in Australia's registered therapeutic goods list, pharmacists must prescribe and sell unapproved products. This has made pharmacists cautious about supplying e-cigarettes. Data from the pharmacy industry shows that the majority of people are not willing to stock e-cigarettes, with a survey finding that 86% of pharmacies do not stock them.

 

Richard Lee, CEO of pharmaceutical company Liber Pharmaceuticals, stated that despite a slow start, the pharmacy's e-cigarette program is progressing within a reasonable range. The slow progress is partially due to the timing of the introduction of new regulations and the implementation phase. Lee expects pharmacies to gradually adapt to the new regulations and achieve significant growth within the next three to six months.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | Clear Tank, Airflow Control and Three-Dimension Flavor Labels: RELX Launches Disposable DIVA in South Korea
Product | Clear Tank, Airflow Control and Three-Dimension Flavor Labels: RELX Launches Disposable DIVA in South Korea
RELX has recently launched its disposable e-cigarette, the RELX DIVA, on online channels in South Korea, offering two nicotine strengths of 0.98% and 1.98%. Publicly available information shows the device features a 20 mL e-liquid capacity and is rated for around 30,000 puffs, alongside a 750 mAh rechargeable battery and two power modes—BOOST and ECO—at approximately 16W and 13W, respectively.
Feb.05 by 2FIRSTS.ai
Singapore New bill would raise maximum fines to S$200,000 for sellers and S$300,000 for smugglers
Singapore New bill would raise maximum fines to S$200,000 for sellers and S$300,000 for smugglers
A bill introduced in Singapore’s Parliament on Feb. 12 proposes major increases in penalties for vaping-related offences, including higher maximum fines for users, sellers and smugglers. The draft would also rename the current Tobacco (Control of Advertisements and Sale) Act as the Tobacco and Vaporisers Control Act.
Feb.28 by 2FIRSTS.ai
France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
France’s top health agency has confirmed that vaping is less harmful than smoking — but not risk-free — reshaping the country’s regulatory trajectory. As Paris withdraws a proposed vape tax and debates stricter ingredient, emissions and youth-protection rules, the ANSES report signals not prohibition, but tighter technical oversight. For manufacturers, retailers and EU policymakers, France may be previewing Europe’s next phase of nicotine governance.
Special Report
Feb.23
Spain’s Galicia Moves First: Under-18 Vape and Energy Drink Sales and Use Banned
Spain’s Galicia Moves First: Under-18 Vape and Energy Drink Sales and Use Banned
Galicia will implement a new “Minor Health Protection and Addictive Behaviors Prevention” law this Saturday, becoming the first region in Spain to ban the sale and use of vapes for people under 18.
Mar.09 by 2FIRSTS.ai
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11